These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16847598)

  • 1. Paediatric brain-stem gliomas: MRI, FDG-PET and histological grading correlation.
    Kwon JW; Kim IO; Cheon JE; Kim WS; Moon SG; Kim TJ; Chi JG; Wang KC; Chung JK; Yeon KM
    Pediatr Radiol; 2006 Sep; 36(9):959-64. PubMed ID: 16847598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
    Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM
    Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can multiparametric MRI and FDG-PET predict outcome in diffuse brainstem glioma? A report from a prospective phase-II study.
    Goda JS; Dutta D; Raut N; Juvekar SL; Purandare N; Rangarajan V; Arora B; Gupta T; Kurkure P; Jalali R
    Pediatr Neurosurg; 2013; 49(5):274-81. PubMed ID: 25277867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
    Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M
    J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas.
    Song PJ; Lu QY; Li MY; Li X; Shen F
    J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of
    Zukotynski KA; Vajapeyam S; Fahey FH; Kocak M; Brown D; Ricci KI; Onar-Thomas A; Fouladi M; Poussaint TY
    J Nucl Med; 2017 Aug; 58(8):1264-1269. PubMed ID: 28360212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG-PET as a prognostic factor in high-grade astrocytoma.
    De Witte O; Lefranc F; Levivier M; Salmon I; Brotchi J; Goldman S
    J Neurooncol; 2000 Sep; 49(2):157-63. PubMed ID: 11206011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse intrinsic pontine gliomas in children: Interest of robotic frameless assisted biopsy. A technical note.
    Coca HA; Cebula H; Benmekhbi M; Chenard MP; Entz-Werle N; Proust F
    Neurochirurgie; 2016 Dec; 62(6):327-331. PubMed ID: 28120771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation between malignant transformation and tumour recurrence by (68)Ga-bombesin and (18)F-FDG-PET, in patients with low grade gliomas.
    Seiz M; Dimitrakopoulou-Strauss A; Schubert GA; Weinmann C; Strauss LG; Eisenhut M; Tuettenberg J
    Hell J Nucl Med; 2008; 11(3):149-52. PubMed ID: 19081856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium.
    Zukotynski KA; Fahey FH; Kocak M; Alavi A; Wong TZ; Treves ST; Shulkin BL; Haas-Kogan DA; Geyer JR; Vajapeyam S; Boyett JM; Kun LE; Poussaint TY
    J Nucl Med; 2011 Feb; 52(2):188-95. PubMed ID: 21233173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11C-Methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas.
    Gumprecht H; Grosu AL; Souvatsoglou M; Dzewas B; Weber WA; Lumenta CB
    Zentralbl Neurochir; 2007 Feb; 68(1):19-23. PubMed ID: 17487804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F-18 FDG PET-CT in patients with recurrent glioma: comparison with contrast enhanced MRI.
    Santra A; Kumar R; Sharma P; Bal C; Kumar A; Julka PK; Malhotra A
    Eur J Radiol; 2012 Mar; 81(3):508-13. PubMed ID: 21353420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
    Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
    J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 11C-methionine PET for grading and prognostication in gliomas: a comparison study with 18F-FDG PET and contrast enhancement on MRI.
    Singhal T; Narayanan TK; Jacobs MP; Bal C; Mantil JC
    J Nucl Med; 2012 Nov; 53(11):1709-15. PubMed ID: 23055534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications.
    Buczkowicz P; Bartels U; Bouffet E; Becher O; Hawkins C
    Acta Neuropathol; 2014 Oct; 128(4):573-81. PubMed ID: 25047029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grading of cerebral glioma with multiparametric MR imaging and 18F-FDG-PET: concordance and accuracy.
    Yoon JH; Kim JH; Kang WJ; Sohn CH; Choi SH; Yun TJ; Eun Y; Song YS; Chang KH
    Eur Radiol; 2014 Feb; 24(2):380-9. PubMed ID: 24078054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
    Lichy MP; Henze M; Plathow C; Bachert P; Kauczor HU; Schlemmer HP
    Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion.
    Borgwardt L; Højgaard L; Carstensen H; Laursen H; Nowak M; Thomsen C; Schmiegelow K
    J Clin Oncol; 2005 May; 23(13):3030-7. PubMed ID: 15860860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas.
    Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S
    J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.